FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
07/16/2026
Back to search
Official data from USPTO
NORDIC BIOSCIENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
07/16/2026
Trademark type
Combined
Nice classes
5, 42
Filing date
07/19/2023
Registration date
12/23/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/23/2025
Last transaction
07/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
99
Owner location
DK
Examiner
BIBB, SCOTT
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Mark description
The mark consists of an image of three stylized dots connected with lines, with a single dot to the right, all appearing to the left of the wording NORDIC BIOSCIENCE.
Holders and representatives
Holders
Nordic Bioscience A/S
Representatives
Andrew M. Smith Resonate IP, LLC
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
diagnostic biomarker reagents for medical and clinical purposes; diagnostic biomarkers for use individually or in combination to detect tissue formationtissue remodelingtissue destruction; diagnostic biomarker assays to identify disease activity; medical diagnostic biomarker assays to quantify disease activity; medical diagnostic biomarker assays to analyse disease activity; diagnostic kits comprised of medical diagnostic reagents and assays for use in disease detectiondisease analysis and quantifying disease activity; medical diagnostic agents; medical diagnostic reagents; clinical diagnostic agents; clinical diagnostic reagents; medical diagnostic test strips for research and diagnostic use for protein fragment detectiondisease detectiondisease analysis and quantifying disease activity; diagnostic preparations for medical purposes; diagnostic agents for medical use
Class 42
custom design and development of blood-based biomarker assays to identifyquantify and analyse disease activity; custom design and development of diagnostic biomarker reagents for medicalpharmaceuticalscientific purposes; custom design and development of biochemicalpharmaceuticalmedical assays; custom design and development of biomarkers for use individually or in combination to detect tissue formationtissue remodelingtissue destruction; providing scientific and pharmaceutical research in the field of biomarkers and biomarker discovery; medical and scientific researchidentification of predictive and prognostic biomarkers for clinical trials; medical and scientific researchidentifying patients for clinical trials most likely to respond to a given treatment using biomarkers; laboratory services for clinical trials; scientific research in the nature of conducting clinical trials for others; biological research and analysisanalysis of pharmacodynamic data; biological research and analysisanalysis of data relating to biomarkers; development services in the field of diagnostic preparationsequipment and tests; medical and scientific researchconducting clinical testing services for others; providing reagent sample testing and diagnostic services for others for scientific research purposes namely diagnostic testing services; medical research laboratory services; research laboratory services in the fields of medical and pharmaceutical research; adviceinformation and assistance relating to the foregoing
Publications
History of USPTO decisions and trademark events.
32 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
06/28/2026
FIMP
FINAL DISPOSITION PROCESSED
06/28/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/23/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/23/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
12/23/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/04/2025
PUBO
PUBLISHED FOR OPPOSITION
11/04/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/29/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/07/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
10/07/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
10/07/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
10/07/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
10/07/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
03/01/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
02/12/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
02/12/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/05/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/05/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/05/2024
RFNT
REFUSAL PROCESSED BY IB
06/03/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/10/2024
RFRR
REFUSAL PROCESSED BY MPU
05/10/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/04/2024
CNRT
NON-FINAL ACTION WRITTEN
05/03/2024
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
05/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/03/2024
CNRT
NON-FINAL ACTION WRITTEN
05/02/2024
DOCK
ASSIGNED TO EXAMINER
03/25/2024
MAFR
APPLICATION FILING RECEIPT MAILED
09/19/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/15/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
09/14/2023
Continuous trademark protection
Get notified about every new filing that threatens NORDIC BIOSCIENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.